// App-Quantinova.ai

: Nonspecific Tools Performed Better in Discriminating Major Bleeding From Direct Oral Anticoagulants Than Specific Tools in a Real-World Population With Atrial Fibrillation

Researchers

Presenter

  • Alessandra M Campos-Staffico

Principal Investigators

  • Michael P Dorsch

  • Geoffrey Barnes

  • Jasmine A Luzum

Medical Centers

  • Clinical Pharmacy, Univ of Michigan, Ann Arbor, MI

  • University of Michigan, Ann Arbor, MI

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

Disease

  • Arrhythmia

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • rivaroxaban

  • apixaban

Outcome

  • N/A

Study Design

  • Multinational

  • Cohort

Phase

  • N/A

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved